Captain T Cell

BiotechnologySeries ABerlin, Germanycaptaintcell.com

Latest round

Series A

Last raised

Nov 2025

Total raised

$9.1M

Investors

7

About Captain T Cell

Founded in 2019 as a spin-off from Max Delbrück Center, Berlin, and based in Berlin, Germany, Captain T Cell GmbH operates as a biotechnology research company that develops efficacy-enhanced T-cell therapies against solid tumors. As of 2025, Felix Lorenz operates as CEO of the company. Captain T Cell GmbH creates T-cell therapies aimed at persistent solid tumors that do not respond to current treatments. The company provides the TCR-ALLO platform, a novel allogeneic solution that allows for off-the-shelf treatments for different cancers, presenting new options for difficult-to-treat cancer cases.

Who invested in Captain T Cell

7 investors across 2 rounds

See all investors in Captain T Cell

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 2, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Seed

    Nov 10, 2023

    Amount

    $9.1M

    Investors

    Locked

Questions about Captain T Cell

Who invested in Captain T Cell?

Captain T Cell has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Captain T Cell raised?

Captain T Cell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Captain T Cell last raise money?

Captain T Cell's most recent round on record is a Series A, in Nov 2025.

What does Captain T Cell do?

Founded in 2019 as a spin-off from Max Delbrück Center, Berlin, and based in Berlin, Germany, Captain T Cell GmbH operates as a biotechnology research company that develops efficacy-enhanced T-cell therapies against solid tumors.

Where is Captain T Cell headquartered?

Captain T Cell is headquartered in Berlin, Germany.

Which VCs invest in companies like Captain T Cell?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Captain T Cell's stage. Their profiles are linked below.

Raising like Captain T Cell? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.